Race in a bottle: the story of BiDil and racialized medicine in a post-genomic age
Gespeichert in:
Beteilige Person: | |
---|---|
Format: | Buch |
Sprache: | Englisch |
Veröffentlicht: |
New York
Columbia Univ. Press
2012
|
Schlagwörter: | |
Beschreibung: | Includes bibliographical references and index |
Umfang: | XI, 311 S. graph. Darst. |
ISBN: | 9780231162982 0231162987 9780231531276 0231531273 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV040662773 | ||
003 | DE-604 | ||
005 | 20130304 | ||
007 | t| | ||
008 | 130110s2012 xx d||| |||| 00||| eng d | ||
015 | |a GBB290870 |2 dnb | ||
020 | |a 9780231162982 |9 978-0-231-16298-2 | ||
020 | |a 0231162987 |9 0-231-16298-7 | ||
020 | |a 9780231531276 |9 978-0-231-53127-6 | ||
020 | |a 0231531273 |9 0-231-53127-3 | ||
035 | |a (OCoLC)828788947 | ||
035 | |a (DE-599)BVBBV040662773 | ||
040 | |a DE-604 |b ger |e rakwb | ||
041 | 0 | |a eng | |
049 | |a DE-12 | ||
100 | 1 | |a Kahn, Jonathan |e Verfasser |0 (DE-588)1031183507 |4 aut | |
245 | 1 | 0 | |a Race in a bottle |b the story of BiDil and racialized medicine in a post-genomic age |c Jonathan Kahn |
264 | 1 | |a New York |b Columbia Univ. Press |c 2012 | |
300 | |a XI, 311 S. |b graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
500 | |a Includes bibliographical references and index | ||
648 | 7 | |a Geschichte 2000-2012 |2 gnd |9 rswk-swf | |
650 | 4 | |a Hydralazine / Development / History | |
650 | 4 | |a Health and race | |
650 | 4 | |a African Americans / Medical care | |
650 | 4 | |a Pharmacogenetics / Social aspects | |
650 | 4 | |a Pharmaceutical industry / Political aspects / United States | |
650 | 4 | |a Geschichte | |
650 | 4 | |a Gesellschaft | |
650 | 4 | |a Politik | |
650 | 4 | |a Schwarze. USA | |
650 | 0 | 7 | |a Rassenpolitik |0 (DE-588)4115694-8 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Pharmakogenetik |0 (DE-588)4271255-5 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Rassentheorie |0 (DE-588)4152838-4 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Forschung |0 (DE-588)4017894-8 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Medizin |0 (DE-588)4038243-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Unternehmensinteresse |0 (DE-588)4187042-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Hydralazin |0 (DE-588)1031904484 |2 gnd |9 rswk-swf |
651 | 4 | |a USA | |
651 | 7 | |a USA |0 (DE-588)4078704-7 |2 gnd |9 rswk-swf | |
689 | 0 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
689 | 0 | 1 | |a Medizin |0 (DE-588)4038243-6 |D s |
689 | 0 | 2 | |a Forschung |0 (DE-588)4017894-8 |D s |
689 | 0 | 3 | |a Rassentheorie |0 (DE-588)4152838-4 |D s |
689 | 0 | 4 | |a Geschichte 2000-2012 |A z |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
689 | 1 | 1 | |a Hydralazin |0 (DE-588)1031904484 |D s |
689 | 1 | 2 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
689 | 1 | 3 | |a Pharmakogenetik |0 (DE-588)4271255-5 |D s |
689 | 1 | 4 | |a Rassenpolitik |0 (DE-588)4115694-8 |D s |
689 | 1 | 5 | |a Unternehmensinteresse |0 (DE-588)4187042-6 |D s |
689 | 1 | 6 | |a Geschichte 2000-2012 |A z |
689 | 1 | |C b |5 DE-604 | |
942 | 1 | 1 | |c 610.9 |e 22/bsb |f 090511 |g 73 |
942 | 1 | 1 | |c 909 |e 22/bsb |f 090511 |g 73 |
942 | 1 | 1 | |c 330.09 |e 22/bsb |f 090511 |g 73 |
943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-025489503 |
Datensatz im Suchindex
_version_ | 1818976951045455872 |
---|---|
any_adam_object | |
author | Kahn, Jonathan |
author_GND | (DE-588)1031183507 |
author_facet | Kahn, Jonathan |
author_role | aut |
author_sort | Kahn, Jonathan |
author_variant | j k jk |
building | Verbundindex |
bvnumber | BV040662773 |
ctrlnum | (OCoLC)828788947 (DE-599)BVBBV040662773 |
era | Geschichte 2000-2012 gnd |
era_facet | Geschichte 2000-2012 |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02787nam a2200757 c 4500</leader><controlfield tag="001">BV040662773</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20130304 </controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">130110s2012 xx d||| |||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">GBB290870</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780231162982</subfield><subfield code="9">978-0-231-16298-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0231162987</subfield><subfield code="9">0-231-16298-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780231531276</subfield><subfield code="9">978-0-231-53127-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0231531273</subfield><subfield code="9">0-231-53127-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)828788947</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV040662773</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kahn, Jonathan</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1031183507</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Race in a bottle</subfield><subfield code="b">the story of BiDil and racialized medicine in a post-genomic age</subfield><subfield code="c">Jonathan Kahn</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Columbia Univ. Press</subfield><subfield code="c">2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XI, 311 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="648" ind1=" " ind2="7"><subfield code="a">Geschichte 2000-2012</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hydralazine / Development / History</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Health and race</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">African Americans / Medical care</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacogenetics / Social aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry / Political aspects / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Geschichte</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gesellschaft</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Politik</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Schwarze. USA</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Rassenpolitik</subfield><subfield code="0">(DE-588)4115694-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakogenetik</subfield><subfield code="0">(DE-588)4271255-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Rassentheorie</subfield><subfield code="0">(DE-588)4152838-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Forschung</subfield><subfield code="0">(DE-588)4017894-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Medizin</subfield><subfield code="0">(DE-588)4038243-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Unternehmensinteresse</subfield><subfield code="0">(DE-588)4187042-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hydralazin</subfield><subfield code="0">(DE-588)1031904484</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Medizin</subfield><subfield code="0">(DE-588)4038243-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Forschung</subfield><subfield code="0">(DE-588)4017894-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Rassentheorie</subfield><subfield code="0">(DE-588)4152838-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="4"><subfield code="a">Geschichte 2000-2012</subfield><subfield code="A">z</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Hydralazin</subfield><subfield code="0">(DE-588)1031904484</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="3"><subfield code="a">Pharmakogenetik</subfield><subfield code="0">(DE-588)4271255-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="4"><subfield code="a">Rassenpolitik</subfield><subfield code="0">(DE-588)4115694-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="5"><subfield code="a">Unternehmensinteresse</subfield><subfield code="0">(DE-588)4187042-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="6"><subfield code="a">Geschichte 2000-2012</subfield><subfield code="A">z</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="C">b</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="942" ind1="1" ind2="1"><subfield code="c">610.9</subfield><subfield code="e">22/bsb</subfield><subfield code="f">090511</subfield><subfield code="g">73</subfield></datafield><datafield tag="942" ind1="1" ind2="1"><subfield code="c">909</subfield><subfield code="e">22/bsb</subfield><subfield code="f">090511</subfield><subfield code="g">73</subfield></datafield><datafield tag="942" ind1="1" ind2="1"><subfield code="c">330.09</subfield><subfield code="e">22/bsb</subfield><subfield code="f">090511</subfield><subfield code="g">73</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-025489503</subfield></datafield></record></collection> |
geographic | USA USA (DE-588)4078704-7 gnd |
geographic_facet | USA |
id | DE-604.BV040662773 |
illustrated | Illustrated |
indexdate | 2024-12-20T16:20:00Z |
institution | BVB |
isbn | 9780231162982 0231162987 9780231531276 0231531273 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-025489503 |
oclc_num | 828788947 |
open_access_boolean | |
owner | DE-12 |
owner_facet | DE-12 |
physical | XI, 311 S. graph. Darst. |
publishDate | 2012 |
publishDateSearch | 2012 |
publishDateSort | 2012 |
publisher | Columbia Univ. Press |
record_format | marc |
spelling | Kahn, Jonathan Verfasser (DE-588)1031183507 aut Race in a bottle the story of BiDil and racialized medicine in a post-genomic age Jonathan Kahn New York Columbia Univ. Press 2012 XI, 311 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Includes bibliographical references and index Geschichte 2000-2012 gnd rswk-swf Hydralazine / Development / History Health and race African Americans / Medical care Pharmacogenetics / Social aspects Pharmaceutical industry / Political aspects / United States Geschichte Gesellschaft Politik Schwarze. USA Rassenpolitik (DE-588)4115694-8 gnd rswk-swf Pharmakogenetik (DE-588)4271255-5 gnd rswk-swf Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf Rassentheorie (DE-588)4152838-4 gnd rswk-swf Forschung (DE-588)4017894-8 gnd rswk-swf Medizin (DE-588)4038243-6 gnd rswk-swf Unternehmensinteresse (DE-588)4187042-6 gnd rswk-swf Hydralazin (DE-588)1031904484 gnd rswk-swf USA USA (DE-588)4078704-7 gnd rswk-swf USA (DE-588)4078704-7 g Medizin (DE-588)4038243-6 s Forschung (DE-588)4017894-8 s Rassentheorie (DE-588)4152838-4 s Geschichte 2000-2012 z DE-604 Hydralazin (DE-588)1031904484 s Arzneimittelentwicklung (DE-588)4143176-5 s Pharmakogenetik (DE-588)4271255-5 s Rassenpolitik (DE-588)4115694-8 s Unternehmensinteresse (DE-588)4187042-6 s b DE-604 |
spellingShingle | Kahn, Jonathan Race in a bottle the story of BiDil and racialized medicine in a post-genomic age Hydralazine / Development / History Health and race African Americans / Medical care Pharmacogenetics / Social aspects Pharmaceutical industry / Political aspects / United States Geschichte Gesellschaft Politik Schwarze. USA Rassenpolitik (DE-588)4115694-8 gnd Pharmakogenetik (DE-588)4271255-5 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd Rassentheorie (DE-588)4152838-4 gnd Forschung (DE-588)4017894-8 gnd Medizin (DE-588)4038243-6 gnd Unternehmensinteresse (DE-588)4187042-6 gnd Hydralazin (DE-588)1031904484 gnd |
subject_GND | (DE-588)4115694-8 (DE-588)4271255-5 (DE-588)4143176-5 (DE-588)4152838-4 (DE-588)4017894-8 (DE-588)4038243-6 (DE-588)4187042-6 (DE-588)1031904484 (DE-588)4078704-7 |
title | Race in a bottle the story of BiDil and racialized medicine in a post-genomic age |
title_auth | Race in a bottle the story of BiDil and racialized medicine in a post-genomic age |
title_exact_search | Race in a bottle the story of BiDil and racialized medicine in a post-genomic age |
title_full | Race in a bottle the story of BiDil and racialized medicine in a post-genomic age Jonathan Kahn |
title_fullStr | Race in a bottle the story of BiDil and racialized medicine in a post-genomic age Jonathan Kahn |
title_full_unstemmed | Race in a bottle the story of BiDil and racialized medicine in a post-genomic age Jonathan Kahn |
title_short | Race in a bottle |
title_sort | race in a bottle the story of bidil and racialized medicine in a post genomic age |
title_sub | the story of BiDil and racialized medicine in a post-genomic age |
topic | Hydralazine / Development / History Health and race African Americans / Medical care Pharmacogenetics / Social aspects Pharmaceutical industry / Political aspects / United States Geschichte Gesellschaft Politik Schwarze. USA Rassenpolitik (DE-588)4115694-8 gnd Pharmakogenetik (DE-588)4271255-5 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd Rassentheorie (DE-588)4152838-4 gnd Forschung (DE-588)4017894-8 gnd Medizin (DE-588)4038243-6 gnd Unternehmensinteresse (DE-588)4187042-6 gnd Hydralazin (DE-588)1031904484 gnd |
topic_facet | Hydralazine / Development / History Health and race African Americans / Medical care Pharmacogenetics / Social aspects Pharmaceutical industry / Political aspects / United States Geschichte Gesellschaft Politik Schwarze. USA Rassenpolitik Pharmakogenetik Arzneimittelentwicklung Rassentheorie Forschung Medizin Unternehmensinteresse Hydralazin USA |
work_keys_str_mv | AT kahnjonathan raceinabottlethestoryofbidilandracializedmedicineinapostgenomicage |